Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.

Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37317644

about

Proteomic profiling of human HepG2 cells treated with hesperidin using antibody array.

P2860

Q42679012-FE30B606-6C5E-4248-8292-2DCAB2AA4BFD

P2860

Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37317644

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@en

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@nl

type

label

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@en

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@nl

prefLabel

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@en

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@nl

P1433

Q37317644-EB045CA1-6619-4EFB-A243-AC2685F69AD0

P1476

Q37317644-3F6D1B39-7777-470E-A8C1-D03F378DC709

P2093

Q37317644-0C277D3B-635D-4CE7-92C6-6702F368B8B3

Q37317644-1DDC4E1B-6504-4887-856A-98D44FD76741

Q37317644-31BA1E17-5246-4526-88F2-E731263DA634

Q37317644-3A861FFB-94FA-41FF-936A-BA5D197CABE9

Q37317644-3D0A39E9-B044-436E-B328-A9B18B566DE2

Q37317644-3EA86BDD-FF0C-4B63-9349-A5ED6F5E034C

Q37317644-46AC1376-3BF3-4E8C-8741-0287B798C73F

Q37317644-480C1E11-C592-4CA9-A9AF-369CB2CDC72D

Q37317644-521845F6-994F-4295-A6BD-FACADAD5535A

Q37317644-6B1E9A64-BB43-46A5-9921-99CC54543D6F

P2860

Q37317644-014C307C-5EBB-4A4C-B024-9AB6451D0D7C

Q37317644-17084543-6DBF-4C96-ABA2-5FB50AECCFE3

Q37317644-1CEC0213-3F97-474C-A064-8953050E45FD

Q37317644-1FB3E9AB-5D82-43AC-BD0C-66EB9EA79162

Q37317644-208C41C6-4B97-41F4-B560-AD6ED8701EA9

Q37317644-240FC51D-8ACB-42AC-A804-5605AB49AA8A

Q37317644-3060CF77-B448-4747-8AEE-A3FCE40FD0E8

Q37317644-323FC2AC-3440-496B-9A96-0CA0E8E88502

Q37317644-3A24166A-BF3E-457C-996C-6945B3401444

Q37317644-3A864C6C-63CA-4A69-8EB7-6332FAB2DA57

P304

Q37317644-82C9DB70-9FA8-4EE7-8DA8-D436CC51C31F

P31

Q37317644-DAF4EE16-91E2-4144-A25B-03C0B5098799

P356

Q37317644-6373DF06-5F53-494E-8BE6-FFD18383127F

P407

Q37317644-4A569F42-6C96-42A0-8BB2-104DE16644C4

P433

Q37317644-F9BB0EB9-F53B-4A37-9BBA-5F8506B4FEC3

P478

Q37317644-9A4979DC-AD6D-485D-857C-2B58F10BAC99

P50

Q37317644-B1CB6335-FCEC-4ED0-B150-AB553553691F

P577

Q37317644-957DE7C2-7DAD-4BD9-AD3F-F4C372B7E9C1

P5875

Q37317644-45AD98FE-5CE2-457A-9210-D42BD3DDDFBF

P698

Q37317644-3F60E6F6-EBCD-4D11-946C-A8ABD42412F5

P921

Q37317644-61922DE4-F593-4D33-9284-B825E8A657B5

Q37317644-AFB38EB3-8E4A-48DB-AABD-D8B903C6F9F3

P932

Q37317644-4FE2218A-DF57-40F9-B705-130560E6B75D

P356

ONCOTARGET.8760

P1433

P1476

Hsp90 inhibition increases SOC ...... chronic lymphocytic leukemia.

@en

P2093

Amy J Johnson

http://www.w3.org/2001/XMLSchema#string

Amy Lehman

http://www.w3.org/2001/XMLSchema#string

Amy S Ruppert

http://www.w3.org/2001/XMLSchema#string

Christoph Plass

http://www.w3.org/2001/XMLSchema#string

Christopher C Oakes

http://www.w3.org/2001/XMLSchema#string

David M Lucas

http://www.w3.org/2001/XMLSchema#string

Erin Hertlein

http://www.w3.org/2001/XMLSchema#string

Jeffery A Jones

http://www.w3.org/2001/XMLSchema#string

Kami J Maddocks

http://www.w3.org/2001/XMLSchema#string

Leslie Andritsos

http://www.w3.org/2001/XMLSchema#string

P2860

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia

Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease

Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12

Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.

Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.

Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.

STAT3 interacts directly with Hsp90.

P304

28684-28696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.8760

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301611573

http://www.w3.org/2001/XMLSchema#string

P698

27107422

http://www.w3.org/2001/XMLSchema#string

P921

P932

5053755

http://www.w3.org/2001/XMLSchema#string